Solid Biosciences Inc. (SLDB) has a consensus analyst rating of Buy, based on 21 analysts covering the stock. Of those, 16 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for SLDB is $12.50, representing a +50.2% upside from the current price of $8.32. Price targets range from a low of $9.00 to a high of $16.00.
